« Previous
Next »
Titles
- ANDA submissions--amendments to abbreviated new drug applications under GDUFA1
- Acne vulgaris: establishing effectiveness of drugs intended for treatment1
- Adolescent and young adult substance use: federal grants for prevention, treatment, and recovery services and for research : report to Congressional committees1
- Adverse events in long-term-care hospitals: national incidence among Medicare beneficiaries1
- Allergic rhinitis: developing drug products for treatment1
- An analysis of private-sector prices for physicians' services1
- Anthrax: developing drugs for prophylaxis of inhalational anthrax1
- Appropriate use of voluntary consensus standards in premarket submissions for medical devices: guidance for industry and Food and Drug Administration staff1
- Assessing user fees under the Prescription Drug User Fee Amendments of 20171
- Assessing user fees under the biosimilar user fee amendments of 20171
- BCG-unresponsive nonmuscle invasive bladder cancer: developing drugs and biologics for treatment1
- Bioanalytical method validation1
- CBO's long-term Social Security projections: changes since 2017 and comparisons with the Social Security trustees' projections1
- CMS Innovation Center: model implementation and center performance : report to Congressional requesters1
- CMS did not detect some inappropriate claims for durable medical equipment in nursing facilities1
- Chronic obstructive pulmonary disease: use of the St. George's Respiratory Questionnaire as a PRO assessment tool1
- Clarification of orphan designation of drugs and biologics for pediatric subpopulations of common diseases1
- Clinical trial imaging endpoint process standards1
- Coast Guard health records: timely acquisition of new system is critical to overcoming challenges with paper process : report to Congressional requesters1
- Coast Guard health records: timely acquisition of new system is critical to overcoming challenges with paper process : testimony before the Subcommittee on Coast Guard and Maritime Transportation, Committee on Transportation and Infrastructure, House of Representatives1